Nm. Habashi et al., LOW BLOOD-FLOW EXTRACORPOREAL CARBON-DIOXIDE REMOVAL (ECCO(2)R) - A REVIEW OF THE CONCEPT AND A CASE-REPORT, Intensive care medicine, 21(7), 1995, pp. 594-597
Despite advances in respiratory and critical care medicine, the mortal
ity from ARDS remains unchanged. Recent research suggests current vent
ilatory therapy may produce additional lung injury, retarding the reco
very process of the lung. Alternative supportive therapies, such as EC
MO and ECCO(2)R, ultimately may result in less ventilator induced lung
injury. Due to the invasiveness of ECMO/ECCO(2)R, these modalities ar
e initiated reluctantly and commonly not until patients suffer from te
rminal or near-terminal respiratory failure. Low flow ECCO(2)R may off
er advantages of less invasiveness and be suitable for early instituti
on before ARDS becomes irreversible. We describe a patient with ARDS a
nd severe macroscopic barotrauma supported with low flow ECCO(2)R resu
lting in significant CO2 clearance, reduction of peak, mean airway pre
ssures and minute ventilation.